Radiofrequency ablation for biliary malignancies

Elsie T. Mensah, John Martin, Mark Topazian

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Purpose of review Intraductal biliary radiofrequency ablation (RFA) is an emerging therapeutic modality that directly targets malignant biliary strictures during endoscopic retrograde cholangiopancreatography. This article reviews the technology, endoscopic technique, and reported outcomes of endoscopic RFA in the management of malignant biliary strictures. Recent findings Biliary RFA is feasible and has a high technical success rate. Infectious complications and major hemobilia are the main adverse events requiring intervention. It is unclear whether RFA prolongs biliary stent patency or decreases the need for repeated endoscopic interventions. Retrospective studies suggest a possible survival benefit with RFA. Summary Intraductal biliary RFA is a promising modality for management of malignant biliary obstruction. Prospective randomized studies are required to determine whether RFA truly confers a survival benefit or decreases the number of biliary interventions.

Original languageEnglish (US)
Pages (from-to)238-243
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume32
Issue number3
DOIs
StatePublished - Jan 1 2016

Fingerprint

Pathologic Constriction
Hemobilia
Endoscopic Retrograde Cholangiopancreatography
Stents
Neoplasms
Retrospective Studies
Prospective Studies
Technology
Therapeutics

Keywords

  • Bile ducts
  • Biliary tract neoplasms
  • Endoscopic retrograde cholangiopancreatography
  • Radiofrequency catheter ablation
  • Stenosis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Radiofrequency ablation for biliary malignancies. / Mensah, Elsie T.; Martin, John; Topazian, Mark.

In: Current Opinion in Gastroenterology, Vol. 32, No. 3, 01.01.2016, p. 238-243.

Research output: Contribution to journalReview article

Mensah, Elsie T. ; Martin, John ; Topazian, Mark. / Radiofrequency ablation for biliary malignancies. In: Current Opinion in Gastroenterology. 2016 ; Vol. 32, No. 3. pp. 238-243.
@article{c4360bff41f24b20bec871c7627ca61d,
title = "Radiofrequency ablation for biliary malignancies",
abstract = "Purpose of review Intraductal biliary radiofrequency ablation (RFA) is an emerging therapeutic modality that directly targets malignant biliary strictures during endoscopic retrograde cholangiopancreatography. This article reviews the technology, endoscopic technique, and reported outcomes of endoscopic RFA in the management of malignant biliary strictures. Recent findings Biliary RFA is feasible and has a high technical success rate. Infectious complications and major hemobilia are the main adverse events requiring intervention. It is unclear whether RFA prolongs biliary stent patency or decreases the need for repeated endoscopic interventions. Retrospective studies suggest a possible survival benefit with RFA. Summary Intraductal biliary RFA is a promising modality for management of malignant biliary obstruction. Prospective randomized studies are required to determine whether RFA truly confers a survival benefit or decreases the number of biliary interventions.",
keywords = "Bile ducts, Biliary tract neoplasms, Endoscopic retrograde cholangiopancreatography, Radiofrequency catheter ablation, Stenosis",
author = "Mensah, {Elsie T.} and John Martin and Mark Topazian",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/MOG.0000000000000258",
language = "English (US)",
volume = "32",
pages = "238--243",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Radiofrequency ablation for biliary malignancies

AU - Mensah, Elsie T.

AU - Martin, John

AU - Topazian, Mark

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose of review Intraductal biliary radiofrequency ablation (RFA) is an emerging therapeutic modality that directly targets malignant biliary strictures during endoscopic retrograde cholangiopancreatography. This article reviews the technology, endoscopic technique, and reported outcomes of endoscopic RFA in the management of malignant biliary strictures. Recent findings Biliary RFA is feasible and has a high technical success rate. Infectious complications and major hemobilia are the main adverse events requiring intervention. It is unclear whether RFA prolongs biliary stent patency or decreases the need for repeated endoscopic interventions. Retrospective studies suggest a possible survival benefit with RFA. Summary Intraductal biliary RFA is a promising modality for management of malignant biliary obstruction. Prospective randomized studies are required to determine whether RFA truly confers a survival benefit or decreases the number of biliary interventions.

AB - Purpose of review Intraductal biliary radiofrequency ablation (RFA) is an emerging therapeutic modality that directly targets malignant biliary strictures during endoscopic retrograde cholangiopancreatography. This article reviews the technology, endoscopic technique, and reported outcomes of endoscopic RFA in the management of malignant biliary strictures. Recent findings Biliary RFA is feasible and has a high technical success rate. Infectious complications and major hemobilia are the main adverse events requiring intervention. It is unclear whether RFA prolongs biliary stent patency or decreases the need for repeated endoscopic interventions. Retrospective studies suggest a possible survival benefit with RFA. Summary Intraductal biliary RFA is a promising modality for management of malignant biliary obstruction. Prospective randomized studies are required to determine whether RFA truly confers a survival benefit or decreases the number of biliary interventions.

KW - Bile ducts

KW - Biliary tract neoplasms

KW - Endoscopic retrograde cholangiopancreatography

KW - Radiofrequency catheter ablation

KW - Stenosis

UR - http://www.scopus.com/inward/record.url?scp=84963706353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963706353&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000258

DO - 10.1097/MOG.0000000000000258

M3 - Review article

C2 - 27054778

AN - SCOPUS:84963706353

VL - 32

SP - 238

EP - 243

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 3

ER -